DV-601: Completed Phase Ib enrollment

Dynavax completed enrollment of up to 6 patients in the first of 3 cohorts in an open-label, dose-escalation, Polish Phase Ib trial evaluating 6 injections of DV-601 given over 3 months in up to 30 pa...